Can low-grade inflammation raise homocysteine?

Low-grade systemic inflammation and altered one-carbon metabolism are closely linked through a complex, bidirectional biochemical network.

Mechanistic pathways of metabolic demand

• Oxidative activation: Chronic low-grade inflammation—characterized by elevated high-sensitivity CRP (hs-CRP), neutrophils, and monocytes—increases the production of reactive oxygen species (ROS), triggering systemic oxidative stress.
• Glutathione depletion: To neutralize this oxidative burden, the body accelerates glutathione synthesis, shifting metabolic flux toward the transsulfuration pathway to produce cysteine and glutathione.
• Methylation pressure: This metabolic shift increases overall methylation demand. Elevated transmethylation reactions consume S-adenosylmethionine (SAM), directly generating S-adenosylhomocysteine (SAH) and subsequently pushing circulating homocysteine levels higher.

The pathogenic feedback loop

• Pro-oxidant cycle: Accumulated homocysteine acts as a direct pro-oxidant by activating NADPH oxidase and depleting glutathione defenses, compounding the initial oxidative stress.
• Inflammatory amplification: Homocysteine further fuels the inflammatory response by inducing CRP expression in vascular smooth muscle cells via a ROS-NF-κB-dependent signaling mechanism, creating a self-sustaining cycle of vascular injury.

Bottom line

• Low-grade inflammation drives a metabolic cascade that increases oxidative stress and methylation demand, elevating homocysteine levels which then feed back to amplify both oxidative damage and vascular inflammation.